Pilot study of pioglitazone and exercise training effects on basal myocardial substrate metabolism and left ventricular function in hiv-positive individuals with metabolic complications

HIV Clinical Trials

Volumn 14, Issue 6, 2013, Pages 303-312

  Cade, W ^a   Reeds, Dominic ^a   Overton, E ^a   Herrero, Pilar ^a   Waggoner, Alan ^a   Laciny, Erin ^a   Bopp, Coco ^a   Lassa Claxton, Sherry ^a   Gropler, Robert ^a   Peterson, Linda ^a   Yarasheski, Kevin ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

exercise; HIV; insulin resistance; left ventricular dysfunction; metabolic syndrome

Indexed keywords

ANTIVIRUS AGENT; INSULIN; PIOGLITAZONE; TRACER;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIASTOLE; ECHOCARDIOGRAPHY; ENZYME SUBSTRATE; EXERCISE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC DISORDER; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; TRAINING;

EID: 84890478856     PISSN: 15284336     EISSN: 19455771     Source Type: Journal    
DOI: 10.1310/hct1406-303     Document Type: Article

References (48)

1. Cade WT. Left ventricular dysfunction in human immunodeficiency virus infection. J Cardiometab Syndr. 2008;3(2): 83-87.
2. Meng Q, Lima JA, Lai H, et al. Use of HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. J Acquir Immune Defic Syndr. 2002;30(3): 306-310.
3. Hsue PY, Hunt PW, Ho JE, et al. Impact of HIV infection on diastolic function and left ventricular mass. Circ Heart Fail. 2010;3(1): 132-139.
4. Reeds DN, Yarasheski KE, Fontana L, et al. Alterations in liver, muscle, and adipose tissue insulin sensitivity in men with HIV infection and dyslipidemia. Am J Physiol Endocrinol Metab. 2006;290(1): E47-E53.
5. Yarasheski KE, Tebas P, Sigmund C, et al. Insulin resistance in HIV protease inhibitor-associated diabetes. J Acquir Immune Defic Syndr. 1999;21(3): 209-216.
6. Hadigan C, Meigs JB, Corcoran C, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis. 2001;32(1): 130-139.
7. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998;12(7): F51-58.
8. Schmidt HH, Behrens G, Genschel J, et al. Lipid evaluation in HIV-1-positive patients treated with protease inhibitors. Antivir Ther. 1999;4(3): 163-170.
9. Bernal E, Masia M, Padilla S, Gutierrez F. High-density lipoprotein cholesterol in HIV-infected patients: Evidence for an association with HIV-1 viral load, antiretroviral therapy status, and regimen composition. AIDS Patient Care STDS. 2008;22(7): 569-575.
10. Crane HM, Van Rompaey SE, Kitahata MM. Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy. AIDS. 2006;20(7): 1019-1026.
11. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17): 2735-2752.
12. Cade WT, Reeds DN, Overton ET, et al. Effects of human immunodeficiency virus and metabolic complications on myocardial nutrient metabolism, blood flow, and oxygen consumption: A cross-sectional analysis. Cardiovasc Diabetol. 2011;10: 111.
13. Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: A reexamination. Diabetes. 2000;49(5): 677-683.
14. Oakes ND, Thalen P, Aasum E, et al. Cardiac metabolism in mice: Tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes. Am J Physiol Endocrinol Metab. 2006;290(5): E870-881.
15. Belke DD, Larsen TS, Gibbs EM, Severson DL. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am J Physiol Endocrinol Metab. 2000;279(5): E1104-1113.
16. How OJ, Larsen TS, Hafstad AD, et al. Rosiglitazone treatment improves cardiac efficiency in hearts from diabetic mice. Arch Physiol Biochem. 2007;113(4-5): 211-220.
17. Boudina S, Sena S, Theobald H, et al. Mitochondrial energetics in the heart in obesity-related diabetes: Direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes. 2007;56(10): 2457-2466.
18. Tian R, Nascimben L, Ingwall JS, Lorell BH. Failure to maintain a low ADP concentration impairs diastolic function in hypertrophied rat hearts. Circulation. 1997;96(4): 1313-1319.
19. Lam CS, Lyass A, Kraigher-Krainer E, et al. Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community. Circulation. 2011;124(1): 24-30.
20. Cave AC, Ingwall JS, Friedrich J, et al. ATP synthesis during low-flow ischemia: Influence of increased glycolytic substrate. Circulation. 2000;101(17): 2090-2096.
21. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007;115(25): 3213-3223.
22. Aronson D, Rayfield EJ, Chesebro JH. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med. 1997;126(4): 296-306.
23. Oakes ND, Kennedy CJ, Jenkins AB, Laybutt DR, Chisholm DJ, Kraegen EW. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat. Diabetes. 1994;43(10): 1203-1210.
24. Szmitko PE, Teoh H, Stewart DJ, Verma S. Adiponectin and cardiovascular disease: State of the art? Am J Physiol Heart Circ Physiol. 2007;292(4): H1655-H1663.
25. Hallsten K, Virtanen KA, Lonnqvist F, et al. Enhancement of insulin-stimulated myocardial glucose uptake in patients with type 2 diabetes treated with rosiglitazone. Diabet Med. 2004;21(12): 1280-1287.
26. Lautamaki R, Airaksinen KE, Seppanen M, et al. Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease: A 16-week randomized, double-blind, placebo-controlled study. Diabetes. 2005;54(9): 2787-2794.
27. Orozco LJ, Buchleitner AM, Gimenez-Perez G, Roque IFM, Richter B, Mauricio D. Exercise or exercise and diet for preventing type 2 diabetes mellitus. Cochrane Database Syst Rev. 2008(3): CD003054.
28. Thomas DE, Elliott EJ, Naughton GA. Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2006(3): CD002968.
29. O'Brien K, Nixon S, Tynan AM, Glazier R. Aerobic exercise interventions for adults living with HIV/AIDS. Cochrane Database Syst Rev. 2010(8): CD001796.
30. O'Brien K, Nixon S, Glazier RH, Tynan AM. Progressive resistive exercise interventions for adults living with HIV/ AIDS. Cochrane Database Syst Rev. 2004(4): CD004248.
31. Fritz T, Krämer DK, Karlsson HKR, et al. Low-intensity exercise increases skeletal muscle protein expression of PPAR-delta and UCP3 in type 2 diabetic patients. Diabetes Metab Res Rev. 2006;22(6): 492-498.
32. Kramer DK, Al-Khalili L, Guigas B, Leng Y, Garcia-Roves PM, Krook A. Role of AMP kinase and PPAR-d in the regulation of lipid and glucose metabolism in human skeletal muscle. J Biol Chem. 2007;282(27): 19313-19320.
33. Soto PF, Herrero P, Schechtman KB, et al. Exercise training impacts the myocardial metabolism of older individuals in a gender-specific manner. Am J Physiol Heart Circ Physiol. 2008;295(2): H842-850.
34. Yarasheski KE, Cade WT, Overton ET, et al. Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity. Am J Physiol Endocrinol Metab. 2011;300(1): E243-251.
35. Mondy K, Overton ET, Grubb J, et al. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population. Clin Infect Dis. 2007;44(5): 726-734.
36. Bashir A, Laciny E, Lassa-Claxton S, Yarasheski KE. Magnetic resonance imaging for quantifying regional adipose tissue in human immunodeficiency virus-infected persons with the cardiometabolic syndrome. J Cardiometab Syndr. 2008;3(2): 115-118.
37. Young ME, Razeghi P, Cedars AM, Guthrie PH, Taegtmeyer H. Intrinsic diurnal variations in cardiac metabolism and contractile function. Circ Res. 2001;89(12): 1199-1208.
38. Bergmann SR, Herrero P, Markham J, Weinheimer CJ, Walsh MN. Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol. 1989;14(3): 639-652.
39. Herrero P, Weinheimer CJ, Dence C, Oellerich WF, Gropler RJ. Quantification of myocardial glucose utilization by PET and 1-carbon-11-glucose. J Nucl Cardiol. 2002;9(1): 5-14.
40. Bergmann SR, Weinheimer CJ, Markham J, Herrero P. Quantitation of myocardial fatty acid metabolism using PET. J Nucl Med. 1996;37(10): 1723-1730.
41. Buck A, Wolpers HG, Hutchins GD, et al. Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. J Nucl Med. 1991;32(10): 1950-1957.
42. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12): 1440-1463.
43. Lansang MC, Williams GH, Carroll JS. Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension. Am J Hypertens. 2001;14: 51-53.
44. Yarasheski KE, Tebas P, Claxton S, et al. Visceral adiposity, C-peptide levels, and low lipase activities predict HIV-dyslipidemia. Am J Physiol Endocrinol Metab. 2003;285(4): E899-905.
45. Spierer DK, DeMeersman RE, Kleinfeld J, et al. Exercise training improves cardiovascular and autonomic profiles in HIV. Clin Auton Res. 2007;17(6): 341-348.
46. Mutimura E, Crowther NJ, Cade TW, Yarasheski KE, Stewart A. Exercise training reduces central adiposity and improves metabolic indices in HAART-treated HIV-positive subjects in Rwanda: A randomized controlled trial. AIDS Res Hum Retroviruses. 2008;24(1): 15-23.
47. Yarasheski KE, Tebas P, Stanerson B, et al. Resistance exercise training reduces hypertriglyceridemia in HIVinfected men treated with antiviral therapy. J Appl Physiol. 2001;90(1): 133-138.
48. Hsue PY, Hunt PW, Ho JE, et al. Impact of HIV infection on diastolic function and left ventricular mass. Circ Heart Fail. 2010;3(1): 132-139.